FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

396050000: Etonogestrel (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1469990019 Etonogestrel (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1489676011 Etonogestrel en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Etonogestrel Is a Progestational hormone false Inferred relationship Existential restriction modifier
Etonogestrel Is a Synthetic progestogen true Inferred relationship Existential restriction modifier
Etonogestrel Has disposition Progestational hormone false Inferred relationship Existential restriction modifier
Etonogestrel Is a Steroid hormone true Inferred relationship Existential restriction modifier
Etonogestrel Is a Norsteroid true Inferred relationship Existential restriction modifier
Etonogestrel Has disposition Progesterone receptor agonist true Inferred relationship Existential restriction modifier
Etonogestrel Is a Estrane true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing etonogestrel Has active ingredient True Etonogestrel Inferred relationship Existential restriction modifier 1
Etonogestrel 68mg subdermal implant Has active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Ethinyl estradiol + etonogestrel 2.7mg/11.7mg vaginal ring Has active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Insertion of etonogestrel implant Direct substance False Etonogestrel Inferred relationship Existential restriction modifier 1
Insertion of etonogestrel implant Direct substance True Etonogestrel Inferred relationship Existential restriction modifier 1
Removal of etonogestrel implant Direct substance False Etonogestrel Inferred relationship Existential restriction modifier 1
Removal of etonogestrel implant Direct substance False Etonogestrel Inferred relationship Existential restriction modifier 1
Insertion of etonogestrel radiopaque contraceptive implant Direct substance True Etonogestrel Inferred relationship Existential restriction modifier 4
Etonogestrel-releasing implant Has active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Product containing etonogestrel in subcutaneous dose form (medicinal product form) Has active ingredient False Etonogestrel Inferred relationship Existential restriction modifier 1
Etonogestrel Has active ingredient True Etonogestrel Inferred relationship Existential restriction modifier 1
Product containing only etonogestrel in parenteral dose form (medicinal product form) Has active ingredient True Etonogestrel Inferred relationship Existential restriction modifier 1
Product containing precisely etonogestrel 68 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has precise active ingredient True Etonogestrel Inferred relationship Existential restriction modifier 1
Product containing precisely etonogestrel 68 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has basis of strength substance True Etonogestrel Inferred relationship Existential restriction modifier 1
Product containing only etonogestrel in subcutaneous dose form (medicinal product form) Has active ingredient False Etonogestrel Inferred relationship Existential restriction modifier 1
Product containing etonogestrel in parenteral dose form (medicinal product form) Has active ingredient True Etonogestrel Inferred relationship Existential restriction modifier 1
Insertion of Implanon Direct substance True Etonogestrel Inferred relationship Existential restriction modifier 1
Insertion of etonogestrel radiopaque contraceptive implant Direct substance False Etonogestrel Inferred relationship Existential restriction modifier 1
Removal of etonogestrel radiopaque contraceptive implant Direct substance False Etonogestrel Inferred relationship Existential restriction modifier 1
Etonogestrel 68mg subdermal implant - product Has active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Implanon 68mg subdermal implant Has active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) 3 system Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg implant Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg implant Has specific active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Implanon 68mg implant (Organon Laboratories Ltd) Has active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg implant 1 device Has active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Implanon 68mg implant (Organon Laboratories Ltd) 1 device Has active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Nexplanon 68mg implant (DE Pharmaceuticals) 1 device Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
Nexplanon 68mg implant (DE Pharmaceuticals) Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (DE Pharmaceuticals) 3 system Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (DE Pharmaceuticals) Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system Has active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) Has active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
Ethinylestradiol + Etonogestrel Has active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg implant 1 device Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
Implanon 68mg implant (Organon Laboratories Ltd) 1 device Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
Implanon 68mg implant (Organon Laboratories Ltd) Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg subdermal implant Has specific active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Nexplanon 68mg implant (Organon Pharma (UK) Ltd) Has active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
Nexplanon 68mg implant (Organon Pharma (UK) Ltd) Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
Nexplanon 68mg implant (Organon Pharma (UK) Ltd) 1 device Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Waymade Healthcare Plc) Has active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Waymade Healthcare Plc) Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Waymade Healthcare Plc) 3 system Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg implant (J M McGill Ltd) Has active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg implant (J M McGill Ltd) Has specific active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg implant (J M McGill Ltd) 1 device Has specific active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg implant (Colorama Pharmaceuticals Ltd) Has active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg implant (Colorama Pharmaceuticals Ltd) Has specific active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg implant (Colorama Pharmaceuticals Ltd) 1 device Has specific active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Ethinylestradiol 2.7mg / Etonogestrel 11.7mg vaginal delivery system (Colorama Pharmaceuticals Ltd) Has active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Ethinylestradiol 2.7mg / Etonogestrel 11.7mg vaginal delivery system (Colorama Pharmaceuticals Ltd) Has specific active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg implant (Ennogen Healthcare Ltd) Has active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg implant (Ennogen Healthcare Ltd) Has specific active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Ethinylestradiol 2.7mg / Etonogestrel 11.7mg vaginal delivery system (Colorama Pharmaceuticals Ltd) 3 system Has specific active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg implant (Ennogen Healthcare Ltd) 1 device Has specific active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg implant (Niche Pharma Ltd) Has active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg implant (Niche Pharma Ltd) Has specific active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Etonogestrel 68mg implant (Niche Pharma Ltd) 1 device Has specific active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Ethinylestradiol 2.7mg / Etonogestrel 11.7mg vaginal delivery system (Ennogen Healthcare Ltd) Has active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Ethinylestradiol 2.7mg / Etonogestrel 11.7mg vaginal delivery system (Ennogen Healthcare Ltd) Has specific active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
Ethinylestradiol 2.7mg / Etonogestrel 11.7mg vaginal delivery system (Ennogen Healthcare Ltd) 3 system Has specific active ingredient False Etonogestrel Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) Has active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system Has specific active ingredient True Etonogestrel Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start